Healthcare Global Enterprises Ltd. NSE: HCG | BSE: 539787

Momentum Trap

Download real time

569.95 23.60 (4.32%)

65.23% Gain from 52W Low

256.8K

NSE+BSE Volume

NSE 15 Jul, 2025 3:31 PM (IST)

Healthcare Global Enterprises Ltd. share price target

Healthcare Global Enterprises Ltd. has an average share price target of 594.60. The consensus estimate represents an upside of 4.32% from the last price of 569.95. View 13 reports from 5 analysts offering long-term price targets for Healthcare Global Enterprises Ltd..

Reco - This broker has downgraded this stock from it's previous report.
(eg. - Buy->Hold)

Target - Broker has maintained previous recommendation but reduced share price target.

Reco - This broker has upgraded this stock from it's previous report.
(eg. - Sell->Hold)

Target - Broker has maintained previous recommendation but increased share price target.

Load latest Google or static link led you to an intermediate page.

Click on any table column to sort reports by date, stock name, broker, price, target, upside or recommendation.

Summary	Date	Stock	Author	LTP	Target	Price at reco (Change since reco%)	Upside(%)	Type	Report		Discuss
	16 Jul 2025	Healthcare Global	Consensus Share Price Target	569.95	567.29	-	-0.47	buy	pdf Detailed Estimates
	14 Aug 2023	Healthcare Global	Axis Direct Target	569.95	364.00	331.55 (71.90%)	Target met	Buy	pdf post cache		Broker Report Result Update:Health.Global Axis Direct Company Outlook & Guidance: Oncology is the fastest-growing industry in the healthcare market with a CAGR of 13.5% during FY22-FY27E. HCG is expected to outpace the industry growth and register a CAGR of 15% during FY23-FY26E due to its strong leadership position in the industry. pdf Copy Link Share on Share on Share on Share on Alert
	14 Aug 2023	Healthcare Global	ICICI Securities Limited Target	569.95	360.00	331.05 (72.16%)	Target met	Accumulate	pdf post cache		Broker Report Surging occupancies drive the need for M&A ICICI Securities Limited HCG’s Q1FY24 revenue growth of 4.3% QoQ was mainly driven by day care services. Installation of 5 LINACs (under pay for use model) led to a dip in radiation oncology services impacting revenue and gross margins. Four of the five new LINACs are operational and the management expects to restore its EBITDA margin by the end of Q4FY24, while it may add a few more LINACs in FY25. pdf Copy Link Share on Share on Share on Share on Alert
	27 May 2023	Healthcare Global	Prabhudas Lilladhar	569.95	375.00	293.75 (94.03%)	Target met	Buy	pdf post cache		Broker Report HEALTHCARE GLOBAL EN Prabhudas Lilladhar pdf Copy Link Share on Share on Share on Share on Alert
	27 May 2023	Healthcare Global	ICICI Securities Limited Reco Target	569.95	330.00	293.75 (94.03%)	Target met	Accumulate	pdf post cache		Broker Report Near-term prospects adequately priced in ICICI Securities Limited HealthCare Global Enterprises’ (HCG) Q4FY23 performance was in line with expectations. Traction was driven by mature centres though incremental revenue in new centres is not improving profitability in a meaningful way. pdf Copy Link Share on Share on Share on Share on Alert
	26 May 2023	Healthcare Global	ICICI Direct Target	569.95	390.00	293.75 (94.03%)	Target met	Buy	pdf post cache		Broker Report Healthcare Global Enterprises ICICI Direct pdf Copy Link Share on Share on Share on Share on Alert
	21 Mar 2023	Healthcare Global	Geojit BNP Paribas Reco Target	569.95	303.00	261.85 (117.66%)	Target met	Accumulate	pdf post cache		Broker Report HEALTHCARE GLOBAL ENTERPRISES LIMITED Geojit BNP Paribas pdf Copy Link Share on Share on Share on Share on Alert
	14 Feb 2023	Healthcare Global	Axis Direct Target	569.95	310.00	279.35 (104.03%)	Target met	Buy	pdf post cache		Broker Report Result Update:Health.Global Axis Direct We maintain BUY on Stock pdf Copy Link Share on Share on Share on Share on Alert
	11 Feb 2023	Healthcare Global	Prabhudas Lilladhar	569.95	375.00	282.35 (101.86%)	Target met	Buy	pdf post cache		Broker Report HEALTHCARE GLOBAL EN Prabhudas Lilladhar pdf Copy Link Share on Share on Share on Share on Alert
	10 Feb 2023	Healthcare Global	ICICI Securities Limited Target	569.95	358.00	282.35 (101.86%)	Target met	Buy	pdf post cache		Broker Report Robust quarter! ICICI Securities Limited HealthCare Global Enterprises’ (HCG) Q3FY23 performance was in line on revenue front, but a miss on profitability. Revenue grew 18.6% YoY (+1.1% QoQ) to Rs4.2bn (I Sec: Rs4.3bn) driven by increased occupancy levels. EBITDA margin was up 50bps YoY and flat QoQ at 17.8%. pdf Copy Link Share on Share on Share on Share on Alert
	10 Feb 2023	Healthcare Global	ICICI Direct Target	569.95	385.00	282.35 (101.86%)	Target met	Buy	pdf post cache		Broker Report Healthcare Global Enterprises ICICI Direct pdf Copy Link Share on Share on Share on Share on Alert
more loading

* Please note that subscribers can download a maximum of 300 reports a month and 70 reports everyday.

Advisor Screeners